Search

Your search keyword '"Forrest, Donna L"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Forrest, Donna L" Remove constraint Author: "Forrest, Donna L" Database Academic Search Index Remove constraint Database: Academic Search Index
25 results on '"Forrest, Donna L"'

Search Results

1. Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels

2. Bone Marrow Necrosis in Adult Acute Leukemia and Non-Hodgkin's Lymphoma.

3. Constitutional rearrangements of 7q22 in hematologic malignancies: a new case report

5. Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real‐world outcomes from a population‐based cohort.

6. Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era.

7. Excellent real‐world outcomes of adults with Burkitt lymphoma treated with CODOX‐M/IVAC plus or minus rituximab.

8. Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.

9. The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells.

10. Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1-BCR-ABL-JAK2 Complex.

11. Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.

12. Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy.

13. Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).

14. Response to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia Relapsing in Chronic and Advanced Phase Following Allogeneic Hematopoietic Stem Cell Transplantation

15. IPSS Poor-Risk Karyotype as a Predictor of Outcome for Patients with Myelodysplastic Syndrome following Myeloablative Stem Cell Transplantation

16. Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders

17. Long-Term Outcome of Myeloablative Allogeneic Stem Cell Transplantation for Multiple Myeloma

18. Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors

19. Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma.

20. Early Stem Cell Transplantation for Refractory Acute Leukemia after Salvage Therapy with High-Dose Etoposide and Cyclophosphamide

21. Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.

22. Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation.

23. Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation

24. Serotonin Syndrome after Concomitant Treatment with Linezolid and Meperidine.

Catalog

Books, media, physical & digital resources